2023
DOI: 10.1080/10408444.2023.2194907
|View full text |Cite
|
Sign up to set email alerts
|

25X-NBOMe compounds – chemistry, pharmacology and toxicology. A comprehensive review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 110 publications
0
3
0
Order By: Relevance
“…Some of these also exhibit pronounced selectivity for 5-HT 2A R over the two other 5-HT 2 R subtypes, 5-HT 2B R and 5-HT 2C R. 30,31 However, concerns about their safety profiles may hinder the clinical development of compounds from the NBOMe class. 32 Representatives of the NBOMe class have been used as tool compounds to investigate the hypothesis that biased agonists mediating selective activation of specific 5-HT 2A R-coupled downstream pathways may hold therapeutic advantages compared to nonbiased receptor agonists. These investigations have led too the development of biased agonists with promising in vitro profiles, but their clinical potential is yet to be investigated.…”
Section: ■ Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…Some of these also exhibit pronounced selectivity for 5-HT 2A R over the two other 5-HT 2 R subtypes, 5-HT 2B R and 5-HT 2C R. 30,31 However, concerns about their safety profiles may hinder the clinical development of compounds from the NBOMe class. 32 Representatives of the NBOMe class have been used as tool compounds to investigate the hypothesis that biased agonists mediating selective activation of specific 5-HT 2A R-coupled downstream pathways may hold therapeutic advantages compared to nonbiased receptor agonists. These investigations have led too the development of biased agonists with promising in vitro profiles, but their clinical potential is yet to be investigated.…”
Section: ■ Introductionmentioning
confidence: 99%
“…The N -benzyl phenethylamine (NBOMe) class of compounds derived from N-benzylation of the 2C-X’s include some of the most potent 5-HT 2A R agonists reported to date. Some of these also exhibit pronounced selectivity for 5-HT 2A R over the two other 5-HT 2 R subtypes, 5-HT 2B R and 5-HT 2C R. , However, concerns about their safety profiles may hinder the clinical development of compounds from the NBOMe class …”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation